These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19489277)

  • 1. [Establishment of long-term culture system for human B cells derived from peripheral blood mononuclear cells activated via soluble CD40 ligand].
    Wu C; Liu Y; Zhao Q; Chen GM; Chen JH; Yan XM; Zhou YH; Huang ZH
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(2):124-7. PubMed ID: 19489277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC.
    Ivanov R; Aarts T; Hagenbeek A; Hol S; Ebeling S
    Cytotherapy; 2005; 7(1):62-73. PubMed ID: 16040385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid cells formed by fusion of Epstein-Barr virus-associated B-lymphoblastoid cells and either marrow-derived or solid tumour-derived cell lines display different co-stimulatory phenotypes and abilities to activate allogeneic T-cell responses in vitro.
    Cywinski AL; Dunnion DJ; Teobald I; Tucker VC; Browning MJ
    Tissue Antigens; 2006 Aug; 68(2):115-26. PubMed ID: 16866881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-Lymphocytes activated by CD40 ligand induce an antigen-specific anti-tumour immune response by direct and indirect activation of CD8(+) T-cells.
    Ritchie DS; Yang J; Hermans IF; Ronchese F
    Scand J Immunol; 2004 Dec; 60(6):543-51. PubMed ID: 15584965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD40 ligand-activated B cells from patients with chronic hepatitis B virus infection as antigen presenting cells to induce hepatitis B virus specific cytotoxic T lymphocytes.
    Liu Y; Huang R; Xiong Y; Zhao Q; Chen G; Xia J; Wu C
    Biochem Biophys Res Commun; 2014 Jul; 450(1):61-6. PubMed ID: 24866241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD40 ligand-activated human peripheral B cells as surrogated antigen presenting cells: A preliminary approach for anti-HBV immunotherapy.
    Wu C; Liu Y; Zhao Q; Chen G; Chen J; Yan X; Zhou YH; Huang Z
    Virol J; 2010 Dec; 7():370. PubMed ID: 21176236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A membrane-bound form of IL-4 enhances proliferation and antigen presentation of CD40-activated human B cells.
    Park JY; Yoon SH; Kim EK; Yun SO; Park MY; Sohn HJ; Kim TG
    Immunol Lett; 2008 Feb; 116(1):33-40. PubMed ID: 18096249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of B cells using Schneider 2 cells expressing CD40 ligand for the enhancement of antigen presentation in vitro.
    Yoon SH; Cho HI; Kim TG
    Exp Mol Med; 2005 Dec; 37(6):567-74. PubMed ID: 16391518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human platelets can activate peripheral blood B cells and increase production of immunoglobulins.
    Cognasse F; Hamzeh-Cognasse H; Lafarge S; Chavarin P; Cogné M; Richard Y; Garraud O
    Exp Hematol; 2007 Sep; 35(9):1376-87. PubMed ID: 17656005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CD40 ligand impairs the function of peripheral blood angiogenic outgrowth cells and increases neointimal formation after arterial injury.
    Hristov M; Gümbel D; Lutgens E; Zernecke A; Weber C
    Circulation; 2010 Jan; 121(2):315-24. PubMed ID: 20048211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell activation in patients with irritable bowel syndrome (IBS).
    Ohman L; Lindmark AC; Isaksson S; Posserud I; Strid H; Sjövall H; Simrén M
    Neurogastroenterol Motil; 2009 Jun; 21(6):644-50, e27. PubMed ID: 19222763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synovial fluid neutrophils transcribe and express class II major histocompatibility complex molecules in rheumatoid arthritis.
    Cross A; Bucknall RC; Cassatella MA; Edwards SW; Moots RJ
    Arthritis Rheum; 2003 Oct; 48(10):2796-806. PubMed ID: 14558085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy.
    Feldon SE; Park DJ; O'Loughlin CW; Nguyen VT; Landskroner-Eiger S; Chang D; Thatcher TH; Phipps RP
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3913-21. PubMed ID: 16249464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD40 ligand (sCD40L) provides a new delivery system for targeted treatment: sCD40L-caspase 3 chimeric protein for treating B-cell malignancies.
    Kedar R; Sabag O; Licthenstein M; Lorberboum-Galski H
    Cancer; 2012 Dec; 118(24):6089-104. PubMed ID: 22692727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Human Soluble CD40 Ligand in Pichia pastoris and Its Effects on Dendritic Cells and Malignant B Cells.
    Shi HZ; Huang WD; Wang YD; Lu Y; Jiang Y; Zhang XG
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2000; 32(6):562-568. PubMed ID: 12058165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 ligand supports the long-term maintenance and differentiation of chicken B cells in culture.
    Kothlow S; Morgenroth I; Tregaskes CA; Kaspers B; Young JR
    Dev Comp Immunol; 2008; 32(9):1015-26. PubMed ID: 18374414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E deficiency enhances the antigen-presenting capacity of Schwann cells.
    Duan RS; Jin T; Yang X; Mix E; Adem A; Zhu J
    Glia; 2007 May; 55(7):772-6. PubMed ID: 17357152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of myeloma-specific cytotoxic T lymphocytes ex vivo by CD40-activated B cells loaded with myeloma tumor antigens.
    Kim SK; Nguyen Pham TN; Nguyen Hoang TM; Kang HK; Jin CJ; Nam JH; Chung SY; Choi SJ; Yang DH; Kim YK; Chung IJ; Kim HJ; Lee JJ
    Ann Hematol; 2009 Nov; 88(11):1113-23. PubMed ID: 19277657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of ovarian carcinoma cells on the maturation and function of human dendritic cells].
    Li CD; Zhang WY; Yuan CL; Han LY
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):630-4. PubMed ID: 19595165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusion of hC3d3 to hCGbeta enhances responsiveness in vitro of human peripheral immunocompetent cells upon the antigen primary challenge.
    Li HP; He XJ; Tang CL; Yao XY; Li DJ
    J Reprod Immunol; 2008 Jul; 78(2):115-24. PubMed ID: 18479753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.